col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


46 Results       Page 1

 [1] 
Wiley: ChemMedChem
  original article Date Title Authors   All Authors
1 [GO] 2026―May―23 Ligand-Based Pharmacophore Modeling and Structure-Based Virtual Screening for Identifying Potential Therapeutic Agents Targeting the SARS-CoV-2 Spike Protein-ACE2 Receptor Interaction Timoteo Delgado-Maldonado, Gilberto Vargas-Salas, Debasish Bandyopadhyay, Adriana Moreno-Rodríguez, Eyra Ortiz-Pérez, Gildardo Rivera
2 [GO] 2026―May―09 Inhibitors Targeting SARS-CoV-2 Papain-Like Protease: Screening, Design, Synthesis, and Biological Evaluation Elena-Oriana Iuga, Nilu Gone, Mariana Ortiz de Godoy, Gabriel Correa Verissimo, Giovanna de Jesus Agostinetto, Liam Urich, et al. (+6)
3 [GO] 2026―Apr―11 2-Phenylquinolines Exhibit Anti-Severe Acute Respiratory Syndrome Coronavirus-2 Activity Through the Nonstructural Protein 13 Helicase Inhibition Giada Cernicchi, Maria Giulia Nizi, Roberta Emmolo, Leentje Persoons, Manon Laporte, Dirk Jochmans, et al. (+19)
4 [GO] 2026―Mar―08 Therapeutic Approaches to Treat SARS-CoV-2 Lekhnath Sharma, Neelesh Maheshwari, Nupur Maheshwari, Ghanshyam Teli, Venkatesh Chelvam
5 [GO] 2026―Jan―31 Machine Learning-Guided Repositioning of a SARS-CoV-2-Targeting Molecular Series as Cruzain Inhibitors Rafael F. Lameiro, Luiz F. Barbosa, Evelin R. Cardoso, Beatriz Siqueira Ho, Felipe Cardoso Prado Martins, Bruna C. de Melo, et al. (+5)
6 [GO] 2025―Nov―23 Allosteric Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase Based on N , N′ -Diphenylurea Artem Chayka, Matěj Danda, Alžběta Dostálková, Vojtěch Spiwok, Lamija Zijadic, Anna Klimešová, et al. (+6)
7 [GO] 2025―May―05 Structure-Activity Relationships of New 1-Aryl-1H-indole Derivatives as SARS-CoV-2 Nsp13 Inhibitors Valentina Noemi Madia, Roberta Emmolo, Elisa Patacchini, Donatella Amatore, Stefania Maloccu, Davide Ialongo, et al. (+13)
8 [GO] 2025―Mar―11 Peptides Corresponding to the Receptor-Binding Domain (RBD) of Several SARS-CoV-2 Variants Of Concern Prevent Recognition of the Human ACE2 Receptor and Consecutive Cell Infections Mandy Schwarze, Alexandra Brakel, Ralf Hoffmann, Andor Krizsan
9 [GO] 2024―Sep―11 Structural basis for inhibition of the SARS-CoV-2 nsp16 by substrate-based dual site inhibitors Gints Kalnins, Laura Rudusa, Anna Bula, Diana Zelencova-Gopejenko, Olga Bobileva, Mihails Sisovs, et al. (+4)
10 [GO] 2024―Aug―14 Developing Allosteric Inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase Artem Chayka, Matěj Danda, Alžběta Dostálková, Vojtěch Spiwok, Anna Klimešová, Marina Kapisheva, et al. (+5)
11 [GO] 2024―Jul―08 Discovery of Fluorescent Naturally-occurring Inhibitor of SARS-CoV-2 Main Protease By AIE Fluorescent Probe Chong-Jing Zhang, Hao Lin
12 [GO] 2024―May―17 Front Cover: Identification of Potential Inhibitors of the SARS-CoV-2 NSP13 Helicase via Structure-Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations (ChemMedChem 10/2024) Giorgio Di Paco, Marina Macchiagodena, Piero Procacci
13 [GO] 2024―Mar―08 Identification of Potential inhibitors of the SARS-CoV-2 NSP13 Helicase via Structure-Based Ligand   Design, Molecular Docking and Nonequilibrium Alchemical Simulations Giorgio Di Paco, Marina Macchiagodena, Piero Procacci
14 [GO] 2023―May―30 A patent review on SARS coronavirus papain-like protease (PLpro) inhibitors. C. S. Brian Chia, Siew Pheng Lim
15 [GO] 2023―Feb―22 A critical study on acylating and covalent reversible fragment inhibitors of SARS-CoV-2 main protease targeting the S1-site with pyridine Rebekka Wamser, Szymon Pach, Christoph Arkona, Morris Baumgardt, Umer Bin Abdul Aziz, Andreas C. Hocke, et al. (+2)
16 [GO] 2022―Oct―03 Effects of the 5'-Triphosphate Metabolites of Ribavirin, Sofosbuvir, Vidarabine, and Molnupiravir on CTP Synthase. Implications for Repurposing Antiviral Agents Against SARS-CoV-2 Thomas D. Gillis, Stephen L. Bearne
17 [GO] 2022―Sep―27 Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS-CoV-2 and Covid-19 Arun K Ghosh, Jennifer L. Mishevich, Andrew Mesecar, Hiroaki Mitsuya
18 [GO] 2022―Aug―29 Toward a Home Test for COVID 19 Diagnosis: DNA Machine for Amplification-Free SARS-CoV-2 Detection in Clinical Samples Ahmed A. ElDeeb, Sofia S. Zablotskaya, Maria S. Rubel, Moustapha A. Y. Nour, Liubov I. Kozlovskaya, Anna A. Shtro, et al. (+2)
19 [GO] 2022―Jun―20 Corrigendum: Promising Therapeutic Approach for SARS-CoV-2 Infections by Using a Rutin-Based Combination Therapy Monika Mazik
20 [GO] 2022―May―02 One Solution for All: Searching for Universal Aptamers for Constantly Mutating Spike Proteins of SARS-CoV-2 Jiuxing Li, Zijie Zhang, Ryan Amini, Yingfu Li
21 [GO] 2022―Apr―30 Promising therapeutic approach for SARS-CoV-2 infection by using a rutin-based combination therapy Monika Mazik
22 [GO] 2022―Feb―21 Synthesis and In Vitro Study of Artemisinin/Synthetic Peroxide Based Hybrid Compounds against SARS-CoV-2 and Cancer Lars Herrmann, Ivan A. Yaremenko, Aysun Çapcı, Julia Struwe, Dhanir Tailor, Arpit Dheeraj, et al. (+8)
23 [GO] 2022―Feb―08 Corrigendum: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease Chia-Chuan Cho, Shuhua G. Li, Tyler J. Lalonde, Kai S. Yang, Ge Yu, Yuchen Qiao, et al. (+2)
24 [GO] 2022―Feb―03 Synthesis of Dihydrobenzofuro[3,2-b]chromenes as a potential 3CLpro inhibitors of SARS-CoV-2: A  molecular docking and dynamics simulation study Sudip Gorai, Vivek Junghare, Kshama Kundu, Sowmomita Gharui, Mukesh Kumar, Birija Sankar Patro, et al. (+3)
25 [GO] 2022―Jan―27 Mass spectrometric assays reveal discrepancies in inhibition profiles for the SARS-CoV-2 papain-like protease Lennart Brewitz, Jos J. A. G. Kamps, Petra Lukacik, Claire Strain-Damerell, Yilin Zhao, Anthony Tumber, et al. (+4)
26 [GO] 2022―Jan―07 Front Cover: MPI8 is Potent against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin L (ChemMedChem 1/2022) Xinyu R. Ma, Yugendar R. Alugubelli, Yuying Ma, Erol C. Vatansever, Danielle A. Scott, Yuchen Qiao, et al. (+3)
27 [GO] 2021―Dec―10 Corrigendum: New Pyrazine Conjugates: Synthesis, Computational Studies, and Antiviral Properties against SARS-CoV-2 Israa A. Seliem, Adel S. Girgis, Yassmin Moatasim, Ahmed Kandeil, Ahmed Mostafa, Mohamed A. Ali, et al. (+2)
28 [GO] 2021―Dec―06 Front Cover: Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses (ChemMedChem 23/2021) Maria Grazia Martina, Ilaria Vicenti, Lisa Bauer, Emmanuele Crespan, Enrico Rango, Adele Boccuto, et al. (+10)
29 [GO] 2021―Dec―01 Structure-Activity Studies Reveal Scope for Optimisation of Ebselen-Type Inhibition of SARS-COV-2 Main Protease Siegfried T. D Thun-Hohenstein, Timothy F Suits, Tika R Malla, Anthony Tumber, Lennart Brewitz, Eidarus Salah, et al. (+2)
30 [GO] 2021―Oct―15 A patent review on SARS coronavirus main protease (3CLpro) inhibitors. C. S. Brian Chia, Weijun Xu, Pearly Shuyi Ng
31 [GO] 2021―Aug―23 Drug Repurposing for the SARS-CoV-2 Papain-Like Protease Wenshe Liu, Chia-Chuan Cho, Shuhua G. Li, Tyler J. Lalonde, Kai S. Yang, Ge Yu, et al. (+2)
32 [GO] 2021―Aug―12 Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses Maria Grazia Martina, Ilaria Vicenti, Lisa Bauer, Emmanuele Crespan, Enrico Rango, Adele Boccuto, et al. (+10)
33 [GO] 2021―Aug―05 New pyrazine conjugates: Synthesis, computational studies, and antiviral properties against SARS-CoV-2 Israa A. Seliem, Adel S. Girgis, Yassmin Moatasim, Ahmed Kandeil, Ahmed Mostafa, Mohamed A. Ali, et al. (+2)
34 [GO] 2021―Jul―09 MPI8 is Potent Against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin L Wenshe Liu, R. Xinyu, Yugendar R. Alugubelli, Yuying Ma, Erol C. Vantasever, Danielle A. Scott, et al. (+3)
35 [GO] 2021―Jul―06 Front Cover: Inspecting the Mechanism of Fragment Hits Binding on SARS-CoV-2 M pro by Using Supervised Molecular Dynamics (SuMD) Simulations (ChemMedChem 13/2021) Maicol Bissaro, Giovanni Bolcato, Matteo Pavan, Davide Bassani, Mattia Sturlese, Stefano Moro
36 [GO] 2021―Jun―18 In silico characterization of masitinib interaction with SARS-CoV-2 main protease Ulises Martínez-Ortega, Diego I. Figueroa-Figueroa, Francisco Hernández-Luis, Rodrigo Aguayo-Ortiz
37 [GO] 2021―Jun―01 Poly-L-lysine Glycoconjugates Inhibit DC-SIGN-mediated Attachment of Pandemic Viruses Beat Ernst, Jonathan Cramer, Butrint Aliu, Xiaohua Jiang, Timothy Sharpe, Lijuan Pang, et al. (+2)
38 [GO] 2021―Apr―03 Science’s response to CoVID-19 Yimon Aye, Marcus Long
39 [GO] 2021―Apr―02 Inspecting the mechanism of fragment hit binding on SARS-CoV-2 Mpro by using supervised molecular dynamics (SuMD) simulations. Maicol Bissaro, Giovanni Bolcato, Matteo Pavan, Davide Bassani, Mattia Sturlese, Stefano Moro
40 [GO] 2021―Jan―22 Front Cover: Structure-Activity Relationships of Benzamides and Isoindolines Designed as SARS-CoV Protease Inhibitors Effective against SARS-CoV-2 (2/2021) Armin Welker, Christian Kersten, Christin Müller, Ramakanth Madhugiri, Collin Zimmer, Patrick Müller, et al. (+6)
41 [GO] 2020―Dec―22 Action of dipeptidyl peptidase-4 inhibitors on SARS-CoV-2 main protease Thomas Klein, Herbert Nar, Gisela Schnapp, Oliver Hucke, Timothy C Hardman
42 [GO] 2020―Dec―07 A Quick Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors Wenshe Liu, Kai Yang, Xinyu Ma, Yuying Ma, Yugendar Alugubelli, Danielle Scott, et al. (+16)
43 [GO] 2020―Sep―16 SAR of novel benzamides and isoindolines, designed as SARS-CoV protease inhibitors - effective against SARS-CoV-2 Armin Welker, Christian Kersten, Christin Müller, Ramakanth Madhugiri, Collin Zimmer, Patrick Müller, et al. (+6)
44 [GO] 2020―Jul―23 Targeting SARS-CoV-2 RBD interface: a supervised computational data-driven approach to identify potential modulators Maria Rita Gulotta, Jessica Lombino, Ugo Perricone, Giada De Simone, Nedra Mekni, Maria De Rosa, et al. (+2)
45 [GO] 2020―Jul―14 ACE2, the Receptor that Enables the Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators Lissy Z.F. Gross, Mariana Sacerdoti, Albrecht Piiper, Stefan Zeuzem, Alejandro E. Leroux, Ricardo M. Biondi
46 [GO] 2020―Apr―23 Drug Development and Medicinal Chemistry Efforts Toward SARS-Coronavirus and Covid-19 Therapeutics Arun K Ghosh, Margherita Brindisi, Dana Shahabi, Mackenzie E. Chapman, Andrew D. Mesecar
 [1] 

46 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec